Real Interest in Psychedelics Therapy for Mental Health Began When Psychiatrist Humphrey Osmond Started Experimenting with Mescaline in the Early 1950s Osmond's Subject at the Time Was Aldous Huxley, a... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of September 21st – 27th, 2020.... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 21st – 27th, 2020.... read more →
Canaccord Genuity Released a Comprehensive Research Report on MindMed Complete a with Bullish Buy Rating and Price Target The Leading Psychedelic Drug Development Company Also Submitted an Application to Uplist... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 14th – 20th, 2020.... read more →
The psychedelics business is developing faster now than ever before, kicked off in earnest when the FDA granted a “breakthrough therapy” designation to Compass Pathways in October 2018 and has... read more →
With the global pandemic still raging on, becoming a divisive issue in the U.S. and other countries for a variety of reasons, everyone is looking for real science-based answers to... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of September 7th - 13th, 2020.... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 7th - 13th, 2020.... read more →
In Yet Another Sign That Psychedelics Are Making Their Way Into the Mainstream, Compass Pathways, a UK-Based Psychedelics Startup Focused on Producing Psilocybin, Has Filed for its Initial Public Offering... read more →
